Charles River Acquires Cell and Gene Therapy CDMO Cognate for $875M
Charles River Laboratories chairman, president, and CEO James C. Foster
Charles River Laboratories plans to acquire the cell and gene therapy contract development and manufacturing organization (CDMO) Cognate BioServices for approximately $875 million cash, in...
New Link between Lymphoma Growth and Blood-Brain Barrier Discovered
Central nervous system (CNS) lymphoma is a rare non-Hodgkin lymphoma in which malignant B cells from lymph tissue form in the brain and/or spinal cord or spread from other parts of the body to...
Researchers develop new tool for tackling disseminated intravascular coagulation
Researchers have developed a new tool for addressing disseminated intravascular coagulation (DIC) - a blood disorder that proves fatal in many patients. The technology has not yet entered clinical trials, but in vivo studies...
Functional Limitations in Biotechnology Risk Invalidity for Lack of Enablement – Lexology
On February 11, 2021, the Federal Circuit issued an opinion that suggests that inventions in fields where outcomes are unpredictable, such as biotechnology and chemistry, are more likely to lack enablement if they contain...
Why Vir Biotechnology Stock Is Higher Today – Motley Fool
What happened
Shares of Vir Biotechnology (NASDAQ:VIR) were 12.6% higher as of 12:47 p.m. EST on Wednesday. The big gain came after Vir and GlaxoSmithKline (NYSE:GSK) announced that they're expanding their collaboration to include the...
Creating the Future of Cell and Gene Therapies
Originally Aired: March 31, 2021Time: 8:00 am PT, 11:00 am ET, 17:00 CET
VIEW NOW
Summing up the ground-breaking work that researchers in the cell and gene therapy space are producing is easy if...
Researchers develop non-cereal crop to enhance yields and consumer health
Delivering the benefits of agricultural biotechnology to smallholder farmers requires that resources be directed toward staple food crops. To achieve effect at scale, beneficial traits must be integrated into multiple, elite farmer-preferred varieties with...
Composition of protein solution plays a decisive role in cataract formation
Cataracts are the most common eye ailment in humans. However, the exact processes leading to this condition are not fully understood. A team of researchers headed by the Technical University of Munich (TUM) has...
AI Gets Gene Therapy Over the Immunity Hump
Focusing on a 28-amino-acid segment, investigators generated more than 200,000 variants of the AAV2 wildtype sequence, which yielded some 110,000 viable engineered capsids, half of which surpassed the average diversity of natural AAV serotype...
Red Planet bacterial biotechnology – Cosmos
Scientists have just demonstrated that cyanobacteria can be grown in Mars-like conditions, paving the way for sustainable life-support systems on the Red Planet. Blue-green algae (Gloeocapsa cyanobacteria). Credit: Ed Reschke/Getty Images...
